Literature DB >> 35674946

Deciphering Candida auris Paradoxical Growth Effect (Eagle Effect) in Response to Echinocandins.

Milena Kordalewska1, David S Perlin2.   

Abstract

The paradoxical growth effect (PGE; also known as Eagle effect) is an in vitro phenomenon observed during antifungal susceptibility testing (AFST). In PGE, some fungal isolates grow in medium containing high concentrations of an echinocandin, above the minimal inhibitory concentration (MIC), despite being fully susceptible at lower concentrations. The presence of PGE complicates the assignment of isolates to susceptible or resistant category, especially in the case of newly emerged pathogens like Candida auris, for which susceptibility breakpoints are not established.Here we describe a protocol aiding in the determination of whether a given C. auris isolate is echinocandin-resistant or echinocandin-susceptible but exhibiting paradoxical growth.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antifungal drug resistance; Antifungal susceptibility testing; Candida; Candida auris; Caspofungin; Eagle effect; Echinocandins; Micafungin; Paradoxical growth effect

Mesh:

Substances:

Year:  2022        PMID: 35674946     DOI: 10.1007/978-1-0716-2417-3_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

Review 1.  The Eagle-like effect of echinocandins: what's in a name?

Authors:  Kim Vanstraelen; Katrien Lagrou; Johan Maertens; Joost Wauters; Ludo Willems; Isabel Spriet
Journal:  Expert Rev Anti Infect Ther       Date:  2013-10-18       Impact factor: 5.091

2.  Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris.

Authors:  Elizabeth L Berkow; Shawn R Lockhart
Journal:  Diagn Microbiol Infect Dis       Date:  2017-11-07       Impact factor: 2.803

3.  Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.

Authors:  Francesco Barchiesi; Elisabetta Spreghini; Serena Tomassetti; Daniela Arzeni; Daniele Giannini; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods.

Authors:  E J Ernst; M E Klepser; M E Ernst; S A Messer; M A Pfaller
Journal:  Diagn Microbiol Infect Dis       Date:  1999-02       Impact factor: 2.803

5.  A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.

Authors:  Anuradha Chowdhary; Anupam Prakash; Cheshta Sharma; Milena Kordalewska; Anil Kumar; Smita Sarma; Bansidhar Tarai; Ashutosh Singh; Gargi Upadhyaya; Shalini Upadhyay; Priyanka Yadav; Pradeep K Singh; Vikas Khillan; Neelam Sachdeva; David S Perlin; Jacques F Meis
Journal:  J Antimicrob Chemother       Date:  2018-04-01       Impact factor: 5.790

Review 6.  Mechanisms of echinocandin antifungal drug resistance.

Authors:  David S Perlin
Journal:  Ann N Y Acad Sci       Date:  2015-07-17       Impact factor: 5.691

7.  Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.

Authors:  David A Stevens; Marife Espiritu; Rachana Parmar
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy.

Authors:  Marçal Mariné; F Javier Pastor; Ismail H Sahand; José Pontón; Guillermo Quindós; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

9.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

10.  Sentinel Case of Candida auris in the Western United States Following Prolonged Occult Colonization in a Returned Traveler from India.

Authors:  Michael H Woodworth; David Dynerman; Emily D Crawford; Sarah B Doernberg; Lynn Ramirez-Avila; Paula Hayakawa Serpa; Amy Nichols; Lucy M Li; Amy Lyden; Cristina M Tato; Steve Miller; Joseph L Derisi; Charles Langelier
Journal:  Microb Drug Resist       Date:  2019-06       Impact factor: 3.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.